- Home
- VIRC vs ZNTL Comparison
VIRC vs ZNTL Comparison
Compare VIRC & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRC
- ZNTL
- Stock Information
- Founded
- VIRC 1950
- ZNTL 2014
- Country
- VIRC United States
- ZNTL United States
- Employees
- VIRC N/A
- ZNTL N/A
- Industry
- VIRC Industrial Specialties
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- VIRC Consumer Discretionary
- ZNTL Health Care
- Exchange
- VIRC Nasdaq
- ZNTL Nasdaq
- Market Cap
- VIRC 131.9M
- ZNTL 105.8M
- IPO Year
- VIRC N/A
- ZNTL 2020
- Fundamental
- Price
- VIRC $8.14
- ZNTL $1.31
- Analyst Decision
- VIRC
- ZNTL Buy
- Analyst Count
- VIRC 0
- ZNTL 7
- Target Price
- VIRC N/A
- ZNTL $8.60
- AVG Volume (30 Days)
- VIRC 68.4K
- ZNTL 927.5K
- Earning Date
- VIRC 06-06-2025
- ZNTL 08-08-2025
- Dividend Yield
- VIRC 1.18%
- ZNTL N/A
- EPS Growth
- VIRC N/A
- ZNTL N/A
- EPS
- VIRC 1.25
- ZNTL N/A
- Revenue
- VIRC $253,259,000.00
- ZNTL $26,865,000.00
- Revenue This Year
- VIRC $0.81
- ZNTL N/A
- Revenue Next Year
- VIRC $4.56
- ZNTL N/A
- P/E Ratio
- VIRC $6.83
- ZNTL N/A
- Revenue Growth
- VIRC N/A
- ZNTL N/A
- 52 Week Low
- VIRC $7.79
- ZNTL $1.01
- 52 Week High
- VIRC $18.50
- ZNTL $5.44
- Technical
- Relative Strength Index (RSI)
- VIRC 45.67
- ZNTL 46.07
- Support Level
- VIRC $7.90
- ZNTL $1.31
- Resistance Level
- VIRC $8.80
- ZNTL $1.39
- Average True Range (ATR)
- VIRC 0.40
- ZNTL 0.13
- MACD
- VIRC 0.05
- ZNTL -0.02
- Stochastic Oscillator
- VIRC 31.65
- ZNTL 16.32
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.